A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease
Clinical trial NCT06198712 · RECRUITING
Trial details
- NCT number
- NCT06198712
- Sponsor
- Forma Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-12
- Primary completion
- 2028-02-23
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.